← All trials
NCT05195970
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 24, 2022
- Primary completion
- Dec 31, 2025
- Completion date
- Dec 31, 2026
- First posted
- Jan 19, 2022
- Last posted
- Nov 16, 2022
- Enrollment
- 200
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ConnecticutLead sponsor
- National Institutes of Health (NIH)Collaborator
- National Cancer Institute (NCI)Collaborator
- Cornell UniversityCollaborator
- University of ConnecticutCollaborator
- University of ConnecticutOverall official - principal investigator
- University of ConnecticutReponsible party - principal investigator
- Jackson LaboratoryCollaborator
- California Walnut CommissionCollaborator
- Government of SpainCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.